Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Med Life with Dr. Horton
    • Podcasts
    • Videos
    • Alerts
    • RSS
    • Classified ads
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Activate online account
    • Look up login
    • Earn CPD Credits
    • Members Corner
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
    • Activate subscription
    • Look up login
    • Manage account
    • Manage IPs
    • View Reports
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JPN

User menu

  • Subscribe
  • My alerts
  • My Cart
  • Log in

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JPN
  • Subscribe
  • My alerts
  • My Cart
  • Log in
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Med Life with Dr. Horton
    • Podcasts
    • Videos
    • Alerts
    • RSS
    • Classified ads
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Activate online account
    • Look up login
    • Earn CPD Credits
    • Members Corner
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
    • Activate subscription
    • Look up login
    • Manage account
    • Manage IPs
    • View Reports
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Review

Intravenous immunoglobulin as clinical immune-modulating therapy

Laurent Gilardin, Jagadeesh Bayry and Srini V. Kaveri
CMAJ March 03, 2015 187 (4) 257-264; DOI: https://doi.org/10.1503/cmaj.130375
Laurent Gilardin
Unité 872, Institut national de la santé et de la recherche médicale, and Équipe 16: Immunopathologie et immuno-intervention thérapeutique, Centre de recherche des Cordeliers, Université Pierre et Marie Curie and Université Paris Descartes, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jagadeesh Bayry
Unité 872, Institut national de la santé et de la recherche médicale, and Équipe 16: Immunopathologie et immuno-intervention thérapeutique, Centre de recherche des Cordeliers, Université Pierre et Marie Curie and Université Paris Descartes, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Srini V. Kaveri
Unité 872, Institut national de la santé et de la recherche médicale, and Équipe 16: Immunopathologie et immuno-intervention thérapeutique, Centre de recherche des Cordeliers, Université Pierre et Marie Curie and Université Paris Descartes, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: srini.kaveri@crc.jussieu.fr
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Data supplements

  • Online Appendices

    Files in this Data Supplement:

    • Appendix 1: Official guidelines for intravenous immunoglobulin use
    • Appendix 2: Classification of evidence levels
  • Earn CME Credits

    This article is eligible for 0.5 Mainpro credits.

    Did you read this article?

    More information

    Note: The YES link above may not work in certain versions of Internet Explorer 8. If you are having difficulties with this link, please try another browser.

    Related Articles

    • (2015). Highlights. CMAJ, 187(4), 231. Accessed December 14, 2019. Retrieved from http://www.cmaj.ca/content/187/4/231.
    • Scopus
    • PubMed
    • Google Scholar
    PreviousNext
    Back to top

    In this issue

    Canadian Medical Association Journal: 187 (4)
    CMAJ
    Vol. 187, Issue 4
    3 Mar 2015
    • Table of Contents
    • Index by author

    Article tools

    Respond to this article
    Print
    Download PDF
    Article Alerts
    To sign up for email alerts or to access your current email alerts, enter your email address below:
    Email Article

    Thank you for your interest in spreading the word on CMAJ.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Intravenous immunoglobulin as clinical immune-modulating therapy
    (Your Name) has sent you a message from CMAJ
    (Your Name) thought you would like to see the CMAJ web site.
    Citation Tools
    Intravenous immunoglobulin as clinical immune-modulating therapy
    Laurent Gilardin, Jagadeesh Bayry, Srini V. Kaveri
    CMAJ Mar 2015, 187 (4) 257-264; DOI: 10.1503/cmaj.130375

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    ‍ Request Permissions
    Share
    Intravenous immunoglobulin as clinical immune-modulating therapy
    Laurent Gilardin, Jagadeesh Bayry, Srini V. Kaveri
    CMAJ Mar 2015, 187 (4) 257-264; DOI: 10.1503/cmaj.130375
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • What is the immunologic basis for intravenous immunoglobulin use?
      • For which diseases is intravenous immunoglobulin effective?
      • For which diseases is intravenous immunoglobulin not recommended?
      • What are the adverse effects?
      • Unanswered questions
      • Acknowledgements
      • Footnotes
      • References
    • Figures & Tables
    • Related Content
    • Responses
    • Metrics
    • PDF

    Related Articles

    • Highlights
    • Scopus
    • PubMed
    • Google Scholar

    Cited By...

    • Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies
    • ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis
    • Scopus (31)
    • Google Scholar

    More in this TOC Section

    • Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering
    • Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants
    • The prevention and management of sudden cardiac arrest in athletes
    Show more Review

    Similar Articles

    Collections

    • Topics
      • Neurology
      • Transplant medicine
      • Immunology
      • Drugs: immunologic
      • Dermatology
      • Hematology & transfusion medicine

    Content

    • Current issue
    • Past issues
    • Collections
    • Sections
    • Blog
    • Podcasts
    • Videos
    • Alerts
    • RSS

    Information for

    • Advertisers
    • Authors
    • CMA Members
    • Copyright and Permissions
    • Media
    • Reprint requests
    • Subscribers

    About

    • General Information
    • Journal staff
    • Editorial Board
    • Governance Council
    • Journal Oversight
    • Careers
    • Contact

    Copyright 2019, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

    All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

    Powered by HighWire